CAG exposes land scam in Andhra
Government largesse to private enterprises and individuals cost exchequer Rs 1,784 crore
US keeps India out of Priority Foreign Country list of 'worst IP offenders'
US Trade Representative’s Special 301 Report keeps up pressure on India to fall in line with US’ interests
The natco-pfizer test
Natco’s demand for a voluntary licence from Pfizer will establish how well the compulsory licence process works in India
Drug affordability test
Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …
Karnataka receives lowest solar energy tariff bid till date
Sun Pharma bags solar project by quoting Rs 5.51 per unit; previous lowest bid was for Rs 7 in Odisha
Three pharma units under scanner for exposing workers to polyacrylate hazard
Gujarat High court directs medical check-up of all employees
Will appellate body uphold grant of compulsory licence to cancer drug?
Hearing on Bayer's appeal against manufacture of generic version of Nexavar to conclude this week
Government withdraws NPPA’s power to fix prices of non-essential medicines
Prices of cardiac, diabetes, HIV/AIDS drugs likely to be affected
Indian company gets licence to manufacture and sell patented cancer drug
This is the first-ever compulsory licence given to a generic drug company
Budget 2023-24 live: Greening the economy is among top 7 priorities, says Nirmala Sitharaman in budget speech
Live updates from the budget speech February 1, 2023